A detailed history of Prudential Financial Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Prudential Financial Inc holds 14,214 shares of ADPT stock, worth $79,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,214
Previous 11,665 21.85%
Holding current value
$79,314
Previous $42,000 71.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.37 - $5.12 $8,590 - $13,050
2,549 Added 21.85%
14,214 $72,000
Q2 2024

Aug 13, 2024

BUY
$2.34 - $3.96 $27,296 - $46,193
11,665 New
11,665 $42,000
Q3 2023

Nov 13, 2023

SELL
$5.07 - $8.44 $1.19 Million - $1.98 Million
-234,925 Reduced 45.31%
283,542 $1.55 Million
Q2 2023

Aug 11, 2023

SELL
$6.19 - $8.78 $1.53 Million - $2.17 Million
-247,450 Reduced 32.31%
518,467 $3.48 Million
Q1 2023

May 12, 2023

BUY
$7.8 - $10.11 $4.69 Million - $6.08 Million
601,150 Added 364.85%
765,917 $6.76 Million
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $893,928 - $1.33 Million
142,800 Added 650.07%
164,767 $0
Q3 2022

Nov 04, 2022

BUY
$6.5 - $12.67 $142,785 - $278,321
21,967 New
21,967 $150,000
Q1 2022

May 13, 2022

SELL
$10.12 - $28.9 $66,872 - $190,971
-6,608 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.17 - $36.85 $2,290 - $3,353
-91 Reduced 1.36%
6,608 $243,000
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $60 - $79
2 Added 0.03%
6,699 $267,000
Q2 2021

Aug 16, 2021

BUY
$32.22 - $44.59 $15,948 - $22,072
495 Added 7.98%
6,697 $273,000
Q1 2021

May 12, 2021

BUY
$37.26 - $67.74 $8,607 - $15,647
231 Added 3.87%
6,202 $250,000
Q4 2020

Feb 16, 2021

BUY
$45.01 - $65.47 $268,754 - $390,921
5,971 New
5,971 $353,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $797M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.